Joseph Lewis, 10% Owner, Director at Odonate Therapeutics, Inc. (ODT), bought 200,000 shares at $22.41 ($4.5M) on 2018-03-26, disclosed to the SEC on 2018-03-26.
Open-market purchase of $4.5M ODT by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.94 | 23,407 | $490K | 10.8% |
| 2 | $20.94 | 23,407 | $490K | 10.8% |
| 3 | $23.96 | 42,943 | $1.0M | 22.6% |
| 4 | $23.96 | 42,943 | $1.0M | 22.6% |
| 5 | $22.41 | 33,650 | $754K | 16.6% |
| 6 | $22.41 | 33,650 |
| $754K |
| 16.6% |
| Total | $22.73 avg | 200,000 | $4.5M | 100% |
| Filing → |
| MRTX | SELL | 2020-10-30 | $154.5M | — | Filing → |
| ODT | BUY | 2020-09-30 | $2.9M | — | Filing → |
| ODT | BUY | 2020-09-09 | $3.4M | — | Filing → |